RU2017124983A - Лечение дегенерации сетчатки с использованием клеток-предшественников - Google Patents

Лечение дегенерации сетчатки с использованием клеток-предшественников Download PDF

Info

Publication number
RU2017124983A
RU2017124983A RU2017124983A RU2017124983A RU2017124983A RU 2017124983 A RU2017124983 A RU 2017124983A RU 2017124983 A RU2017124983 A RU 2017124983A RU 2017124983 A RU2017124983 A RU 2017124983A RU 2017124983 A RU2017124983 A RU 2017124983A
Authority
RU
Russia
Prior art keywords
population
birth
cells
cells obtained
tsp
Prior art date
Application number
RU2017124983A
Other languages
English (en)
Russian (ru)
Other versions
RU2017124983A3 (cg-RX-API-DMAC10.html
Inventor
Иан ХАРРИС
Цзин ЦАО
Надин София ДЕЙНЕКА
Original Assignee
Янссен Байотек, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Янссен Байотек, Инк. filed Critical Янссен Байотек, Инк.
Publication of RU2017124983A publication Critical patent/RU2017124983A/ru
Publication of RU2017124983A3 publication Critical patent/RU2017124983A3/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Reproductive Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
RU2017124983A 2014-12-16 2015-12-04 Лечение дегенерации сетчатки с использованием клеток-предшественников RU2017124983A (ru)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201462092658P 2014-12-16 2014-12-16
US62/092,658 2014-12-16
US201562236732P 2015-10-02 2015-10-02
US62/236,732 2015-10-02
PCT/US2015/063931 WO2016099949A2 (en) 2014-12-16 2015-12-04 Treatment of retinal degeneration using progenitor cells

Publications (2)

Publication Number Publication Date
RU2017124983A true RU2017124983A (ru) 2019-01-17
RU2017124983A3 RU2017124983A3 (cg-RX-API-DMAC10.html) 2019-06-05

Family

ID=56110114

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2017124983A RU2017124983A (ru) 2014-12-16 2015-12-04 Лечение дегенерации сетчатки с использованием клеток-предшественников

Country Status (15)

Country Link
US (1) US20160166619A1 (cg-RX-API-DMAC10.html)
EP (1) EP3233096A4 (cg-RX-API-DMAC10.html)
JP (1) JP2018500325A (cg-RX-API-DMAC10.html)
KR (1) KR20170094368A (cg-RX-API-DMAC10.html)
CN (1) CN107249608A (cg-RX-API-DMAC10.html)
AU (1) AU2015363088A1 (cg-RX-API-DMAC10.html)
BR (1) BR112017012581A2 (cg-RX-API-DMAC10.html)
CA (1) CA2970641A1 (cg-RX-API-DMAC10.html)
MX (1) MX2017007953A (cg-RX-API-DMAC10.html)
PH (1) PH12017501028A1 (cg-RX-API-DMAC10.html)
RU (1) RU2017124983A (cg-RX-API-DMAC10.html)
SG (1) SG11201704668PA (cg-RX-API-DMAC10.html)
TW (1) TW201632620A (cg-RX-API-DMAC10.html)
WO (1) WO2016099949A2 (cg-RX-API-DMAC10.html)
ZA (1) ZA201704793B (cg-RX-API-DMAC10.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8790637B2 (en) 2003-06-27 2014-07-29 DePuy Synthes Products, LLC Repair and regeneration of ocular tissue using postpartum-derived cells
MX2018006729A (es) * 2015-12-04 2018-11-09 Janssen Biotech Inc Tratamiento de la degeneracion de la retina mediante el uso de celulas progenitoras.
JP6799248B2 (ja) * 2016-09-28 2020-12-16 澁谷工業株式会社 細胞シートの切断方法
WO2018102174A1 (en) * 2016-12-01 2018-06-07 Janssen Biotech, Inc. Treatment of retinal degeneration using progenitor cells
GB201703058D0 (en) 2017-02-24 2017-04-12 Ucl Business Plc Biomarkers
KR102091567B1 (ko) * 2018-06-15 2020-03-20 인하대학교 산학협력단 오스테오폰틴 단백질 단편을 유효성분으로 함유하는 뇌손상 예방 또는 치료용 약학 조성물
CN109456937A (zh) * 2018-12-27 2019-03-12 广州赛莱拉干细胞科技股份有限公司 一种制备子宫内膜干细胞的培养基以及制备方法
US10758571B1 (en) 2019-04-09 2020-09-01 Combangio, Inc. Processes for making and using a mesenchymal stem cell derived secretome
WO2021207282A2 (en) 2020-04-07 2021-10-14 Combangio, Inc. Lyophilized mesenchymal stem cell derived secretome and uses thereof
CN115998845B (zh) * 2020-10-26 2026-04-10 上海交通大学医学院附属第九人民医院 血小板反应蛋白1在制备预防和/或治疗视网膜损伤的药物中的应用
CN115177717B (zh) * 2022-08-31 2026-02-06 贵州医科大学附属医院 一种治疗眼表及角膜上皮疾病的药物
CN117004554B (zh) * 2023-08-09 2026-01-06 北京燕麝生物科技发展有限公司 一种林麝香腺细胞的培养基及林麝香腺细胞的培养方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8790637B2 (en) * 2003-06-27 2014-07-29 DePuy Synthes Products, LLC Repair and regeneration of ocular tissue using postpartum-derived cells
ES2569780T3 (es) * 2003-06-27 2016-05-12 DePuy Synthes Products, Inc. Células posparto derivadas de tejido placentario y métodos de preparación y uso de las mismas
US9572840B2 (en) * 2003-06-27 2017-02-21 DePuy Synthes Products, Inc. Regeneration and repair of neural tissue using postpartum-derived cells
US20130251670A1 (en) * 2011-09-13 2013-09-26 Aidan Products, Inc Treatment of Macular Edema Utilizing Stem Cell and Conditioned Media Thereof

Also Published As

Publication number Publication date
BR112017012581A2 (pt) 2017-12-26
CN107249608A (zh) 2017-10-13
PH12017501028A1 (en) 2018-03-05
US20160166619A1 (en) 2016-06-16
WO2016099949A2 (en) 2016-06-23
ZA201704793B (en) 2019-01-30
TW201632620A (zh) 2016-09-16
RU2017124983A3 (cg-RX-API-DMAC10.html) 2019-06-05
JP2018500325A (ja) 2018-01-11
EP3233096A2 (en) 2017-10-25
KR20170094368A (ko) 2017-08-17
SG11201704668PA (en) 2017-07-28
EP3233096A4 (en) 2018-08-22
CA2970641A1 (en) 2016-06-23
MX2017007953A (es) 2018-02-09
AU2015363088A1 (en) 2017-06-15

Similar Documents

Publication Publication Date Title
JP2014000094A5 (ja) 臍帯由来細胞を用いた局部的または散在的脳外傷の改善
CA2747794C (en) Treatment of lung and pulmonary diseases and disorders
SA521421559B1 (ar) أجهزة قابلة للزرع للعلاج بالخلايا وطرق ذات الصلة
JOP20200050A1 (ar) عوامل RNAi وتركيبات لتثبيط التعبير عن شبيه آنجيوبويتين 3 (ANGPTL3)، وطرق استخدام
PH12013502399B1 (en) Treatment of intervertebral disc degeneration using human umbilical cord tissue-derived cells
EP4374851A3 (en) Ophthalmic composition for treatment of dry eye disease
PH12015502587A1 (en) Opthalmic nanoemulsion composition containing cyclosporine and method for preparing same
WO2016042163A3 (en) Ophthalmic drug compositions
KR20220103812A (ko) 태반 줄기 세포를 이용하는 척수 손상 및 외상성 뇌 손상의 치료
RU2013141914A (ru) Лечение амиотрофического бокового склероза с использованием полученных из пуповины клеток
AU2015287920A8 (en) Micronized Wharton's Jelly
BR112018007560A2 (pt) composição cosmética tendo bactérias probióticas
JOP20200253A1 (ar) تركيبات وطرق لعلاج الحثل البقعي
WO2015022670A1 (en) Management of osteoarthritis using pooled allogeneic mesenchymal stem cells
RU2017123184A (ru) Лечение глазных патологий с применением клеток-предшественников
WO2019210320A3 (en) Methods and compositions to stimulate retinal regeneration
Ee et al. The therapeutic potential of stem cells for bronchopulmonary dysplasia:“it’s about time” or “not so fast”?
Ji et al. Decellularized matrix of adipose-derived mesenchymal stromal cells enhanced retinal progenitor cell proliferation via the Akt/Erk pathway and neuronal differentiation
CL2020001426A1 (es) Composición tópica oftálmica que comprende ácido dobesilico para tratar enfermedades del segmento posterior del ojo.
RU2018122461A (ru) Лечение дегенерации сетчатки с применением клеток-предшественников
Parameswaran et al. Pluripotent stem cells: A therapeutic source for age-related macular degeneration
PH12018502704A1 (en) Treatment of retinal vascular disease using progenitor cells
AR110947A1 (es) Tratamiento de degeneración de la retina mediante el uso de células progenitoras
JP7076709B2 (ja) 間葉系幹細胞活性化剤
WO2016126122A3 (ko) 연골세포로 분화되고 있는 줄기세포로부터 추출된 엑소좀을 포함하는 연골세포 분화 유도 또는 연골조직 재생용 조성물

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20191001